Cargando…
Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer
Colorectal cancer (CRC) remains one of the deadliest malignancies worldwide despite recent progress in treatment strategies. Though immune checkpoint inhibition has proven effective for a number of other tumors, it offers benefits in only a small group of CRC patients with high microsatellite instab...
Autores principales: | Nussbaum, Yulia I., Manjunath, Yariswamy, Suvilesh, Kanve N., Warren, Wesley C., Shyu, Chi-Ren, Kaifi, Jussuf T., Ciorba, Matthew A., Mitchem, Jonathan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125332/ https://www.ncbi.nlm.nih.gov/pubmed/33946558 http://dx.doi.org/10.3390/ijms22094802 |
Ejemplares similares
-
TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer
por: Shen, Yuanyuan, et al.
Publicado: (2022) -
Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses
por: Suvilesh, Kanve N., et al.
Publicado: (2022) -
Tumor-Cell–Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer
por: Manjunath, Yariswamy, et al.
Publicado: (2020) -
Identification of Immuno-Targeted Combination Therapies Using Explanatory Subgroup Discovery for Cancer Patients with EGFR Wild-Type Gene
por: Kholod, Olha, et al.
Publicado: (2022) -
Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery
por: Kholod, Olha, et al.
Publicado: (2022)